Skip to main content

Table 3 Treatment protocols and follow-up in 5 included patients

From: Clinicopathological analysis of proliferative glomerulonephritis with monoclonal IgG deposits in 5 renal allografts

Patient

1

2

3

4

5

 

Post-KT

1st post-KT biopsy

2nd post-KT biopsy

3rd post-KT biopsy

Post-KT

Post-KT

1st post-KT biopsy

2nd post-KT biopsy

Scr/proteinuria at biopsy

0.77/2.21

  

3.05/6.09

1.2/0.66

1.67/5.5

 

1.33/37.03

Treatment

Plasma exchange

None

None

Rituximab

Pulse steroid + bortezomib

Bortezomib

Sofosbuvir + Daclatasvir + pulse steroid

Bortezomib + plasma exchange

Treatment-related complication

None

  

None

None

Varicella infection

None

None

Follow-up timea

13 months

  

39 months

7 months

11 months

 

1 months

Last follow-up Scr(mg/dl)/Proteinuria(g/d)

Death due to pulmonary infections

  

In dialysis

In dialysis

1.1/−

 

1.25/14

  1. a: follow-up time here denotes the time interval between treatment to last outpatient follow-up